Notifications
The global anticoagulants market, valued at USD 37.65 billion in 2024, is experiencing robust growth due to the rising prevalence of lifestyle diseases such as diabetes, obesity, and hypertension. These conditions increase the risk of developing cardiovascular diseases and other thromboembolic disor...
